[Correspondence of the World Health Organization relative to the editorial by T. Ancelle (Med. Trop. 1996; 56: 347-348)].
Cattand
P
P
Jannin
J
J
D000349:Africa; D000518:Eflornithine / Q000627:therapeutic use; D005602:France; D014943:Global Health; D006801:Humans; D007391:International Cooperation; D008549:Melarsoprol / Q000009:adverse effects / Q000627:therapeutic use; D010419:Pentamidine / Q000627:therapeutic use; D014344:Trypanocidal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014353:Trypanosomiasis, African / Q000517:prevention & control*; D014944:World Health Organization
D014344:Trypanocidal Agents; D010419:Pentamidine; D008549:Melarsoprol; D000518:Eflornithine